Remember the days when they could not seriously now improve gas mileages on cars too?

.

Now imagine this a Canadian doctor In Calgary falsely believed that if he found a cheap, inexpensive cure for cancer that fame, honour, glory , fortune the world would be at his feat, instead he found out that no one wants to finance further his cure, research, especially since the Pharmacy industry rather like to make still instead loads of money from really sick persons. The love of money is still the root of all evil.

.

The reality among cancer researchers is that they’ve cured cancer thousands of times—in mice. But when it comes to ridding humans of the devastating illness, it’s a far different story. It takes much more trial and money too especially if you are not a part of the old Boy’s club.. Cancer Researchers’ biggest challenge: getting industry or governmental support for further research..

.

Back in 2007, Dr. Evangelos Michelakis, a professor at the University of Alberta department of medicine, discovered along with and colleagues that DCA might help slow cancer growth. DCA is a common compound that has been used for years to treat children with inborn mitochondrial diseases, by “boosting” and normalizing their mitochondria. Michelakis wondered whether DCA could also help repair the damage cancer causes to mitochondria. In test of lab rats, his team found that DCA did help reprogram cancer cell mitochondria, thereby stunting the growth of lung, breast and brain tumours in both rats and in human tissue samples. What’s more, the drug left healthy cells healthy, unlike other cancer treatments such as chemotherapy and radiation. Because healthy cells don’t have the same mitochondrial changes as cancer cells, the DCA left them unchanged. This inexpensive drug already in use for other diseases might hold the key to a completely new way of treating cancers — not by killing off cancer cells, but by simply reprogramming them. The finding comes from some exciting Canadian research on patients with brain tumours. The study found that DCA — or dichloroacetate — can shrink the tumours by altering a cancer cell’s metabolism. While the study was small — just five patients were studied — the researchers say their findings are “proof in principle” that the treatment approach works. Dr. Evangelos Michelakis notes that all of the studies they’ve undertaken thus far on DCA have come with the support of the University of Alberta and public donations. The University of Alberta continues to solicit funds to advance the research on DCA. Anyone who would like to donate to the university’s DCA Cancer Research Fund can do so online, or by contacting the university’s Faculty of Medicine. http://www.ctvnews.ca/simple-cheap-drug-holds-cancer-treatment-promise-1.511625

.

An old drug once routinely used as a treatment for schizophrenia appears to have a hidden talent, Canadian researchers have discovered: neutralizing cancer stem cells while leaving healthy cells intact. The discovery is an important one, since traditional chemotherapy and radiation often fail to eradicate cancer stem cells, which are cells that can lurk in the body, replicating themselves over and over, causing certain kinds of cancer to return. But a team of scientists at McMaster University has discovered that thioridazine, a medication used as the antipsychotic and to treat Parkinson’s disease, can target cancer stem cells and change them into cells that are non-cancerous. The next step is to test thioridazine in clinical trials on cancer patients. The first study will focus on 30 patients with acute myeloid leukemia, or AML, whose disease has relapsed after chemotherapy.http://www.ctvnews.ca/old-drug-could-have-new-use-as-cancer-stem-cell-destroyer-1.831495